New Vision has secured 3 million euros from Buysse & Partners to expand its network of ophthalmic centers across Belgium.

Target Company Overview

New Vision, founded in 2015, has pioneered a new model for ophthalmic treatments, offering procedures such as cataract surgeries, refractive lens implants, and eyelid corrections. The company treated its first patients in a rented facility in late 2016 and opened its inaugural owned eye clinic in Laakdal in August 2020. New Vision aims to provide high-quality and accessible ophthalmic care outside traditional hospital settings while adhering to international safety standards.

By addressing critical challenges in the healthcare sector, New Vision positions itself as a vital alternative. The company seeks to alleviate the financial pressures on hospitals and the limited availability of operating rooms, allowing ophthalmologists to treat patients at their own pace. Clear reimbursement agreements between doctors, facilities, and patients facilitate this model, thereby attracting attention from both ophthalmologists and hospitals. This innovative approach has led to increased patient inflow, underscoring the demand for timely ophthalmic care.

Industry Overview in Belgium

In Belgium, the healthcare industry is undergoing significant transformations, driven by rising demand for specialized services and increasing pressure on hospital operations. With an aging population and growing public health concerns, the need for eff

View Source

Similar Deals

EQT CluePoints

2024

Growth Equity & Expansion Capital Pharmaceuticals (NEC) Belgium
Kurma Growth Opportunities, Eurazeo PanTera

2024

Growth Equity & Expansion Capital Proprietary & Advanced Pharmaceuticals Belgium
Five Elms Capital Scilife

2024

Growth Equity & Expansion Capital Pharmaceuticals (NEC) Belgium
Whitestone Tilman

2024

Growth Equity & Expansion Capital Alternative Medicine Belgium
Whitestone Telemis

2024

Growth Equity & Expansion Capital Medical Imaging Systems Belgium
ARCHIMED Xpress Biologics

2023

Growth Equity & Expansion Capital Bio Therapeutic Drugs Belgium

Buysse & Partners

invested in

New Vision

in 2023

in a Growth Equity & Expansion Capital deal

Disclosed details

Transaction Size: $3M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert